
Amanta Healthcare IPO
- Issue price
- ₹126
- Listing price
- ₹135
- +7.14%
- Current price
- ₹234.47
- +86.09%
- Subscribed
- 82.6x
- Issue size
- ₹126 Cr
- Listed on
- 9 Sep 2025
IPO timeline
- Opens1 SepMon
- Closes3 SepWed
- Allotment4 SepThu
- Refunds8 SepMon
- Demat credit8 SepMon
- Listing9 SepTue
Issue details
- Price band
- ₹120 – ₹126 per share
- Issue size
- ₹126 Cr
- Fresh issue
- ₹126 Cr · 1 Cr shares
- Offer for sale
- None
- Issue type
- Fresh capital only
- Face value
- ₹10 per share
- Lot size
- 119 shares
- Minimum investment
- ₹14,994
- Listing on
- BSE, NSE
- Exchange code
- AMANTA · 544502
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Reservation
- QIB
- 50,00,000 shares (50.00% of the Offer)
- NII
- 15,00,000 shares (15.00% of the Offer)
- Retail
- 35,00,000 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on MUFG Intime India- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 4 Sep 2025
- Refunds initiated
- 8 Sep 2025
- Shares credited to demat
- 8 Sep 2025
- Listing
- 9 Sep 2025
Grey market premium (GMP)
- Current GMP
- ₹8
- +6.00%
- Estimated listing price
- ₹134
- Issue price ₹126
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB35.86x
- NII (HNI)209.4x
- Retail54.96x
Financials
- P/E (pre-issue)
- 34.61
- P/E (post-issue)
- 46.61
- EPS (₹)
- 2.70
- RoE
- 12.42%
- RoCE
- 13.72%
- RoNW
- 10.89%
- PAT Margin
- 3.86%
- EBITDA Margin
- 22.11%
- Debt / Equity
- 2.02
- NAV (₹)
- 33.43
Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price on profit for the FY ended 31 Mar 2025.
| Period ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Amanta Healthcare This IPO | ₹126 Cr | 46.59 | 10.89% | 3.86% | 82.6x | +7.14% |
| Kronox Lab Sciences Mainboard · listed 10 Jun 2024 | ₹130.15 Cr | 24.47 | 25.66% | 22.60% | 117.25x | +21.29% |
| Anlon Healthcare Mainboard · listed 3 Sep 2025 | ₹121.03 Cr | 23.57 | 25.51% | 17.06% | 7.12x | +1.10% |
| Hexagon Nutrition Mainboard · listed 12 Jun 2026 | ₹138.87 Cr | 15.35 | 12.12% | 9.81% | 53.68x | +7.22% |
| Gaudium IVF Mainboard · listed 27 Feb 2026 | ₹165 Cr | 22.99 | 41.71% | 26.96% | 7.27x | +5.06% |
| Gujarat Kidney & Super Speciality Mainboard · listed 30 Dec 2025 | ₹250.8 Cr | 61.62 | 36.61% | 23.61% | 5.21x | +5.26% |
| Sai Parenteral's Mainboard · listed 2 Apr 2026 | ₹409 Cr | 72.19 | 5.09% | 8.93% | 1.08x | +2.04% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Amanta Healthcare plans to use the money raised, as stated in the offer document.
- Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat₹70 Cr
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat₹30.13 Cr
- General Corporate Purposes₹6.6 Cr
- Issue Expenses₹19.26 Cr
About Amanta Healthcare
Amanta Healthcare Limited was incorporated in December 1994. It develops, makes and markets sterile liquid products, mainly parenteral products packed in plastic containers. It also makes medical devices. The range includes IV fluids, diluents, ophthalmic solutions and respiratory care products. In medical devices it offers irrigation solutions, first-aid products and eye lubricants. The company sells through three business units: national sales, international sales and product partnering. The IPO was a fresh issue of Rs 126 crore. Rs 70.00 crore and Rs 30.13 crore were planned for two civil construction and machinery projects.
Strengths
- Profit after tax improved from a loss of Rs 2.11 crore in FY2023 to a profit of Rs 10.50 crore in FY2025.
- The EBITDA margin was 22.11%, as per the figures at the source.
- The whole Rs 126 crore issue was fresh capital for the company.
- Rs 100.13 crore of the proceeds was for capacity projects.
- Total borrowing fell from Rs 215.66 crore on 31 March 2023 to Rs 195.00 crore on 31 March 2025.
Risks
- The P/E was 46.59 at the upper band of Rs 126, based on post-issue EPS of Rs 2.70.
- Total borrowing of Rs 195.00 crore on 31 March 2025 was about twice net worth of Rs 96.39 crore.
- Debt to equity was 2.02 on the figures at the source.
- The PAT margin was low at 3.86%.
- Total income slipped from Rs 281.61 crore in FY2024 to Rs 276.09 crore in FY2025.
- Return on net worth was 10.89%, against a P/E of 46.59.
- Promoters held 85.6% before the issue and held 63.56% after it.
Promoters and shareholding
Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Pvt.Ltd
- Promoter holding, pre-issue
- 85.6%
- Promoter holding, post-issue
- 63.56%
Registrar, lead managers and documents
Lead manager
Documents
Amanta Healthcare IPO: common questions
1.When does the Amanta Healthcare IPO open and close?
The Amanta Healthcare IPO opens on 1 Sep 2025 and closes on 3 Sep 2025.
2.What is the price band of the Amanta Healthcare IPO?
The price band is ₹120 – ₹126 per share, with a lot size of 119 shares and a minimum investment of ₹14,994.
3.What is the size of the Amanta Healthcare IPO?
The issue size is ₹126 Cr (Fresh capital only).
4.What is the GMP of the Amanta Healthcare IPO?
The last reported grey market premium is ₹8 per share as of 06 Sep 2025, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Amanta Healthcare IPO allotment?
The basis of allotment is expected on 4 Sep 2025. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.
6.When will the Amanta Healthcare IPO list?
The shares listed on 9 Sep 2025 on BSE, NSE.
7.Who is the lead manager of the Amanta Healthcare IPO?
The book running lead manager is Beeline Capital Advisors Pvt. Ltd., and the registrar is MUFG Intime India Private Limited.
8.What will the money raised in the Amanta Healthcare IPO be used for?
As stated in the offer document, the proceeds are for: Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat; Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat; General Corporate Purposes; Issue Expenses.
9.How can my company launch an IPO like Amanta Healthcare?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393